Navigation Links
Preterm mothers' milk contains less antioxidants than mothers completing their gestation
Date:2/17/2011

This release is available in Spanish.

A study conducted at the University of Granada and at the University Hospital San Cecilio revealed that preterm mothers' milk contains low concentrations of coenzyme Q10. This is a complex of great medical importance, due both to its antioxidant capacity and to its role as a component of the electron transport chain, among other functions.

This study counted with the participation of a group of researchers of the Institute of Nutrition and Food Technology "Jos Mataix" (from to the Andalusian Government research groups AGR-145 and CTS-627), and with the collaboration of the Department of Pediatrics of the University Hospital San Cecilio of Granada, Spain.

The main objective of this study was to analyze the presence of coenzyme Q10 in breast milk and to examine variation in Q10 concentrations in the three stages of breast milk (colostrum, transitional and mature milk). The second goal was to determine whether the milk of mothers at term and that of preterm mothers have different Q10 concentrations.

30 Breastfeeding Mothers

To carry out this study, researchers selected 30 nursing mothers, 15 of which had completed their gestation and 15 were preterm mothers. Three milk samples were taken from each mother: colostrum, transitional and mature milk. Participants were asked to complete a questionnaire about their eating habits, which was processed later with software developed by the Institute of Nutrition and Food Technology "Jos Mataix", of the University of Granada. The milk samples were examined to measure -among other parameters- concentrations of coenzyme Q, tocopherol (isomers a, g and d) and the total antioxidant capacity of breast milk.

The study revealed colostrum CoQ10 concentrations of about 0.4 mol/l in preterm mothers and 0.7 mol/l in term mothers. This means that CoQ10 concentrations in mothers at term are 75% higher than in preterm mothers. Similar results were obtained regarding tocopherol.

Perfect Food

Scientists stress that while breast milk is the perfect food for all newborns, as it provides the nutrients needed for proper development and growth, "in some cases, breastfeeding is not possible and infants are fed with artificial nutrition. Artificial nutrition is intended to be as similar as possible to human breast milk, or at least, to have the same functional effects as breast milk. This requires a deeper understanding of the composition of human breast milk". This is what makes the results obtained of this research so relevant.

Antioxidants

And, although some antioxidants as tocopherol, carotenoids, ascorbic acid, etc. are known, "there are components with antioxidant activity which concentration and presence in breast milk is completely unknown. Coenzyme Q10 which is an antioxidant of great importance- belongs to this group".

The researchers believe that their study will make an important contribution to the area of infant nutrition. "Having a deep understanding of the factors and components of human milk is paramount, as it can help in getting a better infant milk formula. This way, although a newborn can not benefit from breast milk, at least it will be given the opportunity to artificially benefit from the advantages of human milk" the authors state.


'/>"/>

Contact: Julio Jose Ochoa Herrera
jjoh@ugr.es
34-958-241-000 x203
University of Granada
Source:Eurekalert

Related biology news :

1. New research helps explain how progesterone prevents preterm birth
2. New research helps explain how progesterone preventspreterm birth
3. Bacteria possible cause of preterm births
4. Why do preterm deliveries pose cardiovascular risks for moms?
5. Preterm infants may need a boost
6. Late-preterm babies at greater risk for problems later in childhood
7. BUSPH study observes link between decongestant use in pregnant women and lower risk of preterm birth
8. Study shows extremely preterm children are 3 times as likely to have psychiatric disorder
9. March of Dimes provides $2.6 million in new funding for preterm birth research
10. Prepregnancy, obesity and gestational weight gain influence risk of preterm birth
11. Yale researchers may have uncovered the mechanism by which progesterone prevents preterm birth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... Fla. , April 11, 2017 ... and secure authentication solutions, today announced that it ... Intelligence Advanced Research Projects Activity (IARPA) to develop ... Thor program. "Innovation has been a ... IARPA,s Thor program will allow us to innovate ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® test, ... clinically significant acute bacterial and viral respiratory tract infections by testing the ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology: